Skip to main content

Table 5 Total costs over the 12 months before the enrollment and at the end of the following 12 months in the three subgroups of patients of different asthma severity (€/patient/year)

From: Cost of persistent asthma in Italy

 

Baseline

After 12 months

Difference

 

Group A

FEV1 ≥ 80%

Group B

FEV1 < 80 ≥ 60%

Group C

FEV1 < 60%

Group A

FEV1  ≥ 80%

Group B

FEV1 < 80 ≥ 60%

Group C

FEV1 < 60%

Group A

FEV1 ≥ 80%

Group B

FEV1 < 80 ≥ 60%

Group C

FEV1 < 60%

TOTAL COSTS

782.37 (±51.60)

1,592.08 (±159.67)

2,313.83 (±283.61)

709.30 (±30.19)

2,040.61 (±192.66)

2,636.76 (±286.23)

−73.07 (±51.19)

(p < 0.001)

448.52 (±196.20)

(p < 0.001)

322.93 (±316.64)

(p 0.012)

  1. FEV1%: forced expiratory volume in 1 s, predicted values